| Fund Name | Location |
| Beijing Zhong Jinwanwei Touzi Guanli Zhongxin (Youxian Hehuo) | Beijing, Beijing, China |
| Bradford Capital Partners | Pennsylvania, Pittsburgh, United States |
| Capstone Ventures | California, Menlo Park, United States |
| Coyote Ridge Ventures | California, San Francisco, United States |
| Crest Communications Holdings | Archer, Florida, United States |
| DataStadium | Japan, Tokyo |
| Groupe BPCE | France, Ile-de-France, Paris |
| KLab Ventures | Chiyoda, Japan |
| RoundGlass Partners | Bellevue, United States, Washington |
| Samyakth Finserv | India, Maharashtra, Mumbai |
| Stellex Capital Management | New York, New York, United States |
| Tahoe Venture | China, Jiangsu, Suzhou |
| TEL Venture Capital | California, Fremont, United States |
| The Madison Square Garden Company | New York, New York, United States |
| Tokyu Corporation | Chiyoda, Japan |
| Triumph Healthcare | - |
| Vistara Capital Partners | British Columbia, Canada, Vancouver |
| WBC incubator | - |
| Zheda Chuangtou | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Magnolia NeuroSciences | $31M | 13 Aug 2018 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Magnolia NeuroSciences | $31M | 13 Aug 2018 | New York, New York, United States |
